cimb-logo

Journal Browser

Journal Browser

Advances in Molecular Biology Methods in Hepatology Research, 2nd Edition

A special issue of Current Issues in Molecular Biology (ISSN 1467-3045). This special issue belongs to the section "Molecular Medicine".

Deadline for manuscript submissions: 31 January 2026 | Viewed by 52

Special Issue Editors


grade E-Mail Website
Guest Editor
Institute of Molecular Pathobiochemistry, Experimental Gene Therapy and Clinical Chemistry (IFMPEGKC), RWTH University Hospital Aachen, D-52074 Aachen, Germany
Interests: liver disease; fibrosis; biomarker; cytokines; chemokines; translational medicine
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
Institute of Molecular Pathobiochemistry, Experimental Gene Therapy and Clinical Chemistry (IFMPEGKC), RWTH University Hospital Aachen, Aachen, Germany
Interests: molecular biology; liver fibrosis; drug discovery and development; advanced in vitro models
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Recent advances in molecular and cellular biology methods have had profound implications in deciphering the complexities of hepatology research. Specifically, these advancements are helping us to understand how the liver functions and how diseases develop. They are also allowing us to identify novel therapies and drugs and reduce drug toxicity. The integration of genomic technologies such as next-generation sequencing (NGS), single-cell sequencing, CRISPR-Cas9, and epigenetic studies allows for a more thorough analysis of the liver's genomic landscape. Similarly, progress in single-cell proteomic techniques, including sensitive mass spectrometry and high-throughput proteomics, has enabled the identification and quantification of liver proteins at the cellular level. These technologies help scientists comprehend the molecular pathways involved in liver injury, fibrosis, and regeneration. In addition to genomic techniques, the progress in hepatic in vivo models and liver tissue engineering, utilizing technologies such as CRISPR-Cas9, has aided in the creation of humanized organoid models. These technologies, such as hepatic organoids, are scalable for high-throughput screening and can replicate intricate cellular interactions, providing further insights into the mechanisms underlying liver diseases such as metabolic dysfunction-associated steatotic liver disease (MASLD), hepatitis, and liver fibrosis. By generating patient-derived organoids, researchers can personalize disease models, uncover individualized disease mechanisms, and develop efficient toxicity screening platforms and precision therapeutics. Overall, these advancements in molecular biology have propelled hepatology research to new heights, providing additional opportunities for efficient diagnosis, treatment, and prevention strategies for hepatic diseases.

You can read the publications in the first volume here: https://www.mdpi.com/journal/cimb/special_issues/4L8BQQE181.

Prof. Dr. Ralf Weiskirchen
Dr. Dileep G. Nair
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Current Issues in Molecular Biology is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • hepatic diseases
  • molecular biology methods
  • single-cell genomics
  • single-cell proteomics
  • hepatic organoids
  • biomarkers

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers

This special issue is now open for submission.
Back to TopTop